The global CBD gummies market size is expected to reach USD 6.94 billion by 2025, exhibiting a 31.9% CAGR over the forecast period, according to a new report by Grand View Research, Inc. The market is highly fragmented in nature owing to the presence of small and medium scale companies. Majority of the companies are based out of Canada owing to the legalization of cannabis in the country for medical and recreational purpose. The growth is driven by the growing trend of cannabis legalization across the globe. Different governments are legalizing marijuana to eradicate the black market and to boost the tax revenue from legal sales of marijuana products.
Growing consumer interest for cannabis edibles is expected to support the market growth. As per 4A’s, 36% of the Cannabidiol (CBD) consumers used edibles. Three-fourths of the participants associate consumption of CBD with at least one health benefit. Around 56% associate it with pain relief, 47% for anti-anxiety, 34% for sleep-aid, 30% for epilepsy, and 22% for socialization. The market players focus on the consumer trends for planning the business strategies. For instance, in 2019, Plus Products Inc., a California-based edibles company, entered into a partnership with mattress startup company Casper to introduce melatonin- and CBD-infused sleep gummies. The company also partnered up with American artist and philanthropist John Legend for promoting the products.
The players operating in the CBD gummies market are expanding their reach through business partnerships. For instance, in 2019, Plus Products Inc. expands its product offering in Nevada Adult-Use market by signing a partnership agreement with TapRoot, a vertically integrated cannabis company operating with cultivation and manufacturing facilities in Las Vegas, Nevada.
CBD gummies manufacturers are coming up with new ways to create brand value and distribution channel. For instance, in 2018, the first cannabis dispensary in a hotel was established in The Standard Hotel for an LA-based cannabis company, Lord Jones. The hotel stocks the mini bar with canniabidiol gummies in its Los Angeles, New York, and Miami Beach locations.
To gain market share, the companies are focusing on merger and acquisition strategies. For instance, in 2019, Tilary acquired alcoholic cocktail gummy maker, Smith & Sinclair to create a line of CBD edibles. The product will be distributed in U.S. and Canada. This acquisition offers company an opportunity to diversify the product portfolio, differentiate themselves from others, and gain market share.
The companies are also entering into partnerships with distributors. For instance, in 2019, CV Sciences, Inc. expanded their distribution partnership with more than 400 Kroger stores in five new states, including Georgia, Montana, Texas, Utah and Virginia. This partnership will help the company sell its product in 22 states and 1,350 stores across many of Kroger’s retail banners, including Kroger, Dillons, Fry’s, Fred Meyer, King Sooper, Mariano’s, Pick ‘n Save, QFC, and Smiths. The company also partnered up with Southeastern Grocers, Inc. to distribute the products in Florida and South Carolina. Tilray, Inc. in 2019, acquired all of the issued and outstanding securities of 420 Investments Ltd. (FOUR20), an adult-use cannabis retail operator headquartered in Calgary, Alberta.
The market is competitive in nature due to the rising number of new entrants. For Instance, in 2019, Pollen-a new CBD brand-was launched in U.K. offering luxury product, such as CBD gummies, drink drops, and sparkling drinks. Their CBD gummies are available in three flavors, namely, Cacao, lemon, and orange; Turmeric, cayenne, and grapefruit; and Honey and cherry. The companies are also launching new products to gain greater market share. For instance, in 2018, CV Sciences, Inc., supplier and manufacturer of hemp-derived phytocannabinoids announced the launch of PlusCBD Oil Gummies at the Natural Product Expo East 2018. These CBD gummies are available in two flavors-Cherry Mango and Citrus Punch-each containing 5 mg of CBD. They are also gluten free, vegan-friendly, and non-GMO.
Request a free sample copy or view report summary: CBD Gummies Market Report
The high concentration segment is estimated to witness strong growth over the forecasted period. Epilepsy, sleep disorders, schizophrenia, and glaucoma patients are the major consumers of high concentrated CBD gummies with more than 20mg CBD content per gummy
The low/concentrated segment was estimated to be the largest segment in 2018. Newcomers are the major consumers of low CBD content gummies ranging from 1mg to 20 mg of CBD per gummy
North America is estimated to be the fastest and largest market over the forecast period. Legalization of cannabis for medial and recreational purpose is the major factor driving the regional growth
In Europe, U.K. is estimated to be the fastest growing market, owing to growing consumer demand. As per the Cannabis Trade Association, the number of CBD user in U.K. increased from 125,000 in 2016 to 250,000 in 2017
Some of the key players operating in the market include CV Sciences; Dixie Brands Inc.; Reliva CBD Wellness; Sunday Scaries; Green Roads CBD; Medix CBD; Hemp Bombs; Pure Kana; Diamond CBD and Premium Jane
Grand View Research has segmented the global CBD gummies market on the basis of concentration, distribution channel, and region:
CBD Gummies Concentration Outlook (Revenue, USD Million, 2015 - 2025)
CBD Gummies Distribution Channel Outlook (Revenue, USD Million, 2015 - 2025)
CBD Gummies Regional Outlook (Revenue, USD Million, 2015 - 2025)
Rest of the World
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."